Headspace, the San Francisco-based digital mental health leader, has officially announced a significant expansion of its specialty care ecosystem, marking a strategic shift toward providing a comprehensive continuum of care for high-acuity mental health conditions. By entering into strategic partnerships focused on neurodiversity, eating disorders, and substance use disorders, Headspace aims to bridge the gap […]
The administrative burden of the United States healthcare system has long been cited as a primary driver of rising costs and provider burnout, with the process of credentialing and insurance enrollment representing one of the most significant bottlenecks in the industry. On Wednesday, Assured Health, a New York City-based startup, announced it has raised $19 […]
The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Jideytro (zidesamtinib), a targeted therapy for the treatment of adult patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC) who have previously received a ROS1 inhibitor. This regulatory milestone, announced Wednesday, arrived significantly ahead of the agency’s scheduled Prescription Drug […]
Agios Pharmaceuticals has officially terminated the clinical development of tebapivat, an investigational oral PKR activator intended for the treatment of sickle cell disease (SCD), after mid-stage clinical data failed to demonstrate a competitive advantage over existing therapies. The decision, announced following a review of Phase 2 results, marks a strategic pivot for the Cambridge, Massachusetts-based […]
In a legislative move aimed at fundamentally restructuring the competitive landscape of the American health insurance market, U.S. Representative Angie Craig (D-Minnesota) has introduced the Medicare-X Choice Act. The bill, which was formally filed in the House of Representatives last week, seeks to establish a government-run public health insurance option designed to compete directly with […]
The intersection of high-finance speculation and clinical healthcare has reached a new and controversial milestone with the official launch of prediction markets centered on the results of pharmaceutical trials and federal regulatory decisions. Last week, Kalshi, a leading prediction market platform, announced a strategic partnership with the data analytics firm AppliedXL to allow users to […]
The healthcare industry stands at a critical crossroads where the integration of artificial intelligence (AI) and the reinforcement of cybersecurity protocols have become the primary determinants of operational success and patient safety. MedCity News has officially initiated a specialized research project designed to capture the current sentiment, strategic direction, and technological preparedness of healthcare payers […]
The rapid proliferation of artificial intelligence within clinical environments promises to revolutionize patient outcomes and operational efficiency, yet a new report from the Peterson Health Technology Institute (PHTI) warns that the United States’ existing healthcare payment models are fundamentally ill-equipped to handle this transition. The comprehensive analysis, released following an intensive multi-sector workshop, argues that […]
The integration of artificial intelligence into the American healthcare landscape has reached a critical inflection point, where the same machine learning models revolutionizing patient diagnostics and operational efficiency are being weaponized by sophisticated cybercriminals. As hospitals across the United States accelerate their adoption of AI-driven tools to enhance clinical outcomes, they are simultaneously facing a […]
The rapid integration of artificial intelligence (AI) and machine learning (ML) into the medical device sector has created a sophisticated legal and operational paradox for developers and investors alike. At the heart of this challenge lies a fundamental product-design conflict: while the commercial and clinical value of AI often stems from its ability to continuously […]
